伤口闭合后立即注射肉毒毒素对瘢痕质量疗效的系统综述与荟萃分析
该系统综述与荟萃分析纳入9项随机试验和1项前瞻性研究共521例,评估伤口闭合后立即注射肉毒毒素(BTX)对术后瘢痕质量的疗效与安全性。结果显示BTX组温哥华瘢痕量表评分与对照组无显著差异,但视觉模拟量表评分更高且瘢痕宽度更窄,未见不良事件。
要点
- 伤口闭合后立即注射BTX可改善瘢痕外观评分并缩窄瘢痕宽度。
- 温哥华瘢痕量表评分未见显著改善,提示客观量表敏感性有限。
- 纳入研究中未报告不良事件,短期安全性较好。
核心结论
- 伤口闭合后立即注射BTX安全,并可改善术后瘢痕质量。
- BTX最佳注射时机仍需进一步研究以指导临床应用。
研究设计与样本
- 遵循PRISMA 2020指南的系统综述与荟萃分析。
- 检索PubMed、EMBASE、Web of Science和Cochrane至2024年9月10日。
- 纳入9项随机试验和1项前瞻性研究,共521例。
- 排除瘢痕疙瘩或增生性瘢痕治疗、非英文、综述、病例报告、信件和摘要。
主要发现
- BTX组与对照组温哥华瘢痕量表评分无显著差异(MD = -0.35,95%CI = -1.01至0.30,P = 0.29)。
- BTX组视觉模拟量表评分高于对照组(MD = 1.29,95%CI = 0.68至1.90,P < 0.01)。
- BTX组瘢痕宽度较对照组缩窄(MD = -0.19,95%CI = -0.30至-0.09,P < 0.01)。
- 纳入研究中未发现不良事件。
关键数值与推荐
- 当至少3项纳入荟萃分析的研究使用同一经验证的瘢痕评估量表时,方进行该量表的合并分析。
- 采用均数差(MD)比较组间差异。
临床怎么用
- 对于术后瘢痕预防,可考虑在伤口闭合后立即注射BTX以改善外观和缩窄瘢痕。
- 温哥华瘢痕量表未见显著改善,临床评估应结合视觉模拟量表和瘢痕宽度等指标。
- 注射时机仍需个体化,并等待更多研究明确最佳窗口。
局限性
- 纳入研究数量有限(共10项,521例),可能影响结论稳健性。
- 仅纳入英文研究,存在语言偏倚风险。
- 排除瘢痕疙瘩和增生性瘢痕治疗研究,结论不适用于此类瘢痕。
- BTX注射最佳时机尚不明确,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Botulinum toxin (BTX) is considered an efficient and safe therapy for postoperative scars that improves visual and functional quality. However, the optimal timing for injection remains under debate due to conflicting evidence. OBJECTIVE: The aim of this study is to evaluate the efficacy and safety of BTX applied immediately after wound closure in the quality assessment of postoperative scars. METHODS: This is a systematic review and meta-analysis following the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) 2020 guidelines. Searches were performed in PubMed, EMBASE, Web of Science, and Cochrane until September 10, 2024, including randomized or prospective studies on BTX applied immediately after wound closure, with exclusions for keloids or hypertrophic scars treatment studies, non-English studies, reviews, case reports, letters, and abstracts. The quality of scars was assessed using appropriate and widely validated tests and scales when at least 3 studies selected in the meta-analysis utilized them. The mean difference (MD) was used to explore the difference among different groups. RESULTS: Nine randomized trials and 1 prospective study in a total of 521 were identified in this meta-analysis. BTX showed no significant difference in Vancouver Scar Scale score (MD = -0.35, 95% confidence interval [CI] = -1.01 to 0.30, P = 0.29) compared with control, higher visual analog scale score (MD = 1.29, 95% CI = 0.68 to 1.90, P < 0.01), and reduced scar width (MD = -0.19, 95% CI = -0.30 to -0.09, P < 0.01). No adverse events were found in the included studies. CONCLUSIONS: This meta-analysis demonstrated that BTX injections immediately after wound closure are safe and improve scars quality. BTX time of injection requires further studies to provide better clinical applications.
引用
- Silva RAS, Nishizima A, Magalhães PLM, et al. Efficacy of Botulinum Toxin Applied Immediately After Wound Closure on Scars Quality Assessment: A Systematic Review and Meta-analysis. Ann Plast Surg. 2025. PMID: 40549945. doi:10.1097/SAP.0000000000004368
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。